Britain’s FTSE 100 recorded its third consecutive weekly decline after closing 43 points lower, down 0.4%, at 10,233.07 on Friday. The more domestically focused FTSE 250 also ended weaker, slipping 0.15% to close
Britain’s FTSE 100 recorded its third consecutive weekly decline after closing 43 points lower, down 0.4%, at 10,233.07 on Friday. The more domestically focused FTSE 250 also ended weaker, slipping 0.15% to close
Kendrick (LON: KEN) has provided a strategic update on its Teufelskuppe and Kieshöhe rare earth projects in Namibia, outlining plans to accelerate development and advance toward a maiden Mineral Resource
The FTSE 100 edged lower on Friday, closing down around 15 points at just under 10,364. The FTSE 250 showed a more positive tone heading into the bank holiday, rising
Kendrick Resources Plc (LON: KEN) reported a narrower pre-tax loss of £2.60 million for the year ended 29 December 2025, compared with a loss of £3.44 million in the prior
It has been a strong week for the UK’s growth companies, with the AIM All-Share—widely seen as the benchmark for smaller-cap stocks—rising 4.5% as investors looked through geopolitical uncertainty and
For much of 2025, Kendrick Resources (LON: KEN) traded largely under the radar, with its share price hovering around the 0.2p level and attracting limited sustained attention from the wider
Kendrick Resources PLC (LON: KEN) is progressing exploration at its Bonya rare earth project in Namibia, where it holds a 70% interest in the Teufelskuppe and Kieshöhe licences.
The United Kingdom faces a critical petrol shortage at the pumps during the Easter weekend, with retail experts warning of potential diesel shortages within weeks. The confluence of heightened demand, geopolitical
For much of 2025, Kendrick Resources (LON: KEN) traded largely under the radar, with its share price hovering around the 0.2p level and attracting limited sustained attention from the wider
For much of 2025, Kendrick Resources (LON: KEN) traded largely under the radar, with its share price hovering around the 0.2p level and attracting limited sustained attention from the wider
The AIM All-Share slipped slightly on the week and is now down around 7% year-to-date, underlining the pressure on smaller companies. In contrast, the FTSE 100 closed the week at 9,967, slipping just 5
ImmuPharma PLC (IMM), the specialist drug discovery and development company, provided an update on its auto-immune technology platform program, P140. IMM said “The receipt of the first Combined Search and Examination